Company / Book Value per Share
Krystal Biotech, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$42.355
FY2025
5-year range
$20.486 / $42.355
FY2021-FY2025
Trend
+26.4%
vs FY2024
Sector context
#11 of 209
Health Care
What the data says
Among 209 Health Care companies, Krystal Biotech, Inc. is in the top 5% for book value per share. Book Value per Share has increased for 3 consecutive years, from $20.486 in FY2022 to $42.355 in FY2025.
Based on SEC 10-K filings.
$42.355 in FY2025 with a 5-year CAGR of +22.2%. Top quartile in the Health Care sector.
Improved from $30.222 to $42.355 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +27.4%
- 5-Year CAGR
- +22.2%
- 10-Year CAGR
- -
Sector benchmark
-77.6% below sector average
Key checks
Key Insights
- Krystal Biotech, Inc.'s book value per share has grown for 3 consecutive years.
- 5-year CAGR of +22.2%, indicating consistent growth.
- In FY2025, book value per share increased 26.4% year-over-year.
- Ranks #11 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.355 | +26.4% |
| FY2024 | $33.516 | +10.9% |
| FY2023 | $30.222 | +47.5% |
| FY2022 | $20.486 | -23.4% |
| FY2021 | $26.741 | +72.0% |
| FY2020 | $15.547 | +21.8% |
| FY2019 | $12.761 | +26.3% |
| FY2018 | $10.107 | +9.5% |
| FY2017 | $9.229 | +2702.3% |
| FY2016 | $0.329 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026